A Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab with or Without Bevacizumab as Frontline Therapy for Metastatic Colorectal Cancer. A Fox Chase Extramural Research Study
Titel:
A Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab with or Without Bevacizumab as Frontline Therapy for Metastatic Colorectal Cancer. A Fox Chase Extramural Research Study
Auteur:
Dotan, Efrat Meropol, Neal J. Burtness, Barbara Denlinger, Crystal S. Lee, James Mintzer, David Zhu, Fang Ruth, Karen Tuttle, Holly Sylvester, Judi Cohen, Steven J.